Researchers are exploring various approaches to develop a vaccine against the Zika virus, including targeting specific envelope domains and designing vaccines that optimize immunogenicity. Studies are also investigating the structural basis of antibodies against the virus and the potential for cross-reactivity with other flaviviruses, such as dengue. The goal of this research is to create effective protective immune responses against Zika virus infection.